Ying Li

Ying Li

Company: Takeda Pharmaceutical Company

Job title: Companion Diagnostic Lead

Seminars:

Improving Patient Identification Through Precision Diagnostics – CDx for Mobocertinib 9:00 am

Validated CDx test is critical for identifying all EGFR exon 20 insertion patients eligible for treatment with mobocertinib A CDx for tissue sample testing was validated and approved by the FDA simultaneously with mobocertinib A liquid biopsy NGS test has been validated for detection of EGFR exon 20 insertions in NSCLC patientsRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.